BOLT vs MS · rev $7.7M vs P/E 20, $344.27B cap
Bolt Biotherapeutics (BOLT) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
MS does not have a complete income-statement cache yet.
BOLT currently screens at market cap $11.3M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the BOLT and MS stock pages for the full models.
Not investment advice.